Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of AIR001 in PAH
NCT01725269Phase 2Terminated
- Sponsor
- Aires Pharmaceuticals, Inc.
- Start
- Mar 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sodium nitrite in pulmonary arterial hypertension (PAH), sponsored by Aires Pharmaceuticals, Inc.. Started Mar 2013; status: terminated.
02
Drugs
sodium nitrite
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01725269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725269.